Skip to main content
NCBI home page
Molecular Medicine logoLink to Molecular Medicine
. 1996 Nov;2(6):665–669.

The role of candidate genes in the etiology of schizophrenia.

K C Murphy 1, P McGuffin 1
PMCID: PMC2230137  PMID: 8972482

Full text

PDF
665

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arranz M. J., Lin M. W., Powell J., Kerwin R., Collier D. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 1996 Jun 29;347(9018):1831–1832. [PubMed] [Google Scholar]
  2. Arranz M., Collier D., Sodhi M., Ball D., Roberts G., Price J., Sham P., Kerwin R. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet. 1995 Jul 29;346(8970):281–282. doi: 10.1016/s0140-6736(95)92168-0. [DOI] [PubMed] [Google Scholar]
  3. Asherson P., Mant R., Holmans P., Williams J., Cardno A., Murphy K., Jones L., Collier D., McGuffin P., Owen M. J. Linkage, association and mutational analysis of the dopamine D3 receptor gene in schizophrenia. Mol Psychiatry. 1996 May;1(2):125–132. [PubMed] [Google Scholar]
  4. Asherson P., Walsh C., Williams J., Sargeant M., Taylor C., Clements A., Gill M., Owen M., McGuffin P. Imprinting and anticipation. Are they relevant to genetic studies of schizophrenia? Br J Psychiatry. 1994 May;164(5):619–624. doi: 10.1192/bjp.164.5.619. [DOI] [PubMed] [Google Scholar]
  5. Baron M., Gruen R., Levitt M., Hunter C., Asnis L. Erythrocyte catechol O-methyltransferase activity in schizophrenia: analysis of family data. Am J Psychiatry. 1984 Jan;141(1):29–32. doi: 10.1176/ajp.141.1.29. [DOI] [PubMed] [Google Scholar]
  6. Bassett A. S., Honer W. G. Evidence for anticipation in schizophrenia. Am J Hum Genet. 1994 May;54(5):864–870. [PMC free article] [PubMed] [Google Scholar]
  7. Bowen T., Guy C., Speight G., Jones L., Cardno A., Murphy K., McGuffin P., Owen M. J., O'Donovan M. C. Expansion of 50 CAG/CTG repeats excluded in schizophrenia by application of a highly efficient approach using repeat expansion detection and a PCR screening set. Am J Hum Genet. 1996 Oct;59(4):912–917. [PMC free article] [PubMed] [Google Scholar]
  8. Buckland P. R., O'Donovan M. C., McGuffin P. Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment. Psychopharmacology (Berl) 1992;106(4):479–483. doi: 10.1007/BF02244818. [DOI] [PubMed] [Google Scholar]
  9. Buckland P. R., O'Donovan M. C., McGuffin P. Clozapine and sulpiride up-regulate dopamine D3 receptor mRNA levels. Neuropharmacology. 1993 Sep;32(9):901–907. doi: 10.1016/0028-3908(93)90146-t. [DOI] [PubMed] [Google Scholar]
  10. Burnet P. W., Harrison P. J. Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet. 1995 Sep 30;346(8979):909–909. [PubMed] [Google Scholar]
  11. Cardno A. G., Murphy K. C., Jones L. A., Guy C. A., Asherson P., De Azevedo M. H., Coelho I. M., de Macedo e Santos A. J., Pato C. N., McGuffin P. Expanded CAG/CTG repeats in schizophrenia. A study of clinical correlates. Br J Psychiatry. 1996 Dec;169(6):766–771. doi: 10.1192/bjp.169.6.766. [DOI] [PubMed] [Google Scholar]
  12. Coon H., Byerley W., Holik J., Hoff M., Myles-Worsley M., Lannfelt L., Sokoloff P., Schwartz J. C., Waldo M., Freedman R. Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. Am J Hum Genet. 1993 Feb;52(2):327–334. [PMC free article] [PubMed] [Google Scholar]
  13. Crocq M. A., Mant R., Asherson P., Williams J., Hode Y., Mayerova A., Collier D., Lannfelt L., Sokoloff P., Schwartz J. C. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet. 1992 Dec;29(12):858–860. doi: 10.1136/jmg.29.12.858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Daniels J. K., Williams N. M., Williams J., Jones L. A., Cardno A. G., Murphy K. C., Spurlock G., Riley B., Scambler P., Asherson P. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry. 1996 Feb;153(2):268–270. doi: 10.1176/ajp.153.2.268. [DOI] [PubMed] [Google Scholar]
  15. Eberhard G., Ross S., Säf J., Wahlund B., Wetterberg L. Psychoses in twins. A 10 year clinical and biochemical follow-up study. Schizophr Res. 1989 Jul-Oct;2(4-5):367–374. doi: 10.1016/0920-9964(89)90029-7. [DOI] [PubMed] [Google Scholar]
  16. Floderus Y., Ross S. B., Wetterberg L. Erythrocyte catechol-O-methyltransferase activity in a Swedish population. Clin Genet. 1981 May;19(5):389–392. doi: 10.1111/j.1399-0004.1981.tb00731.x. [DOI] [PubMed] [Google Scholar]
  17. Hallmayer J., Kennedy J. L., Wetterberg L., Sjögren B., Kidd K. K., Cavalli-Sforza L. L. Exclusion of linkage between the serotonin2 receptor and schizophrenia in a large Swedish kindred. Arch Gen Psychiatry. 1992 Mar;49(3):216–219. doi: 10.1001/archpsyc.1992.01820030048006. [DOI] [PubMed] [Google Scholar]
  18. Jönsson E., Nöthen M. M., Bunzel R., Propping P., Sedvall G. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 1996 Jun 29;347(9018):1831–1831. [PubMed] [Google Scholar]
  19. Kalsi G., Sherrington R., Mankoo B. S., Brynjolfsson J., Sigmundsson T., Curtis D., Read T., Murphy P., Butler R., Petursson H. Linkage study of the D5 dopamine receptor gene (DRD5) in multiplex Icelandic and English schizophrenia pedigrees. Am J Psychiatry. 1996 Jan;153(1):107–109. doi: 10.1176/ajp.153.1.107. [DOI] [PubMed] [Google Scholar]
  20. Kelly D., Goldberg R., Wilson D., Lindsay E., Carey A., Goodship J., Burn J., Cross I., Shprintzen R. J., Scambler P. J. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11. Am J Med Genet. 1993 Feb 1;45(3):308–312. doi: 10.1002/ajmg.1320450306. [DOI] [PubMed] [Google Scholar]
  21. Lewander T., von Pongracz G., Bäckström M., Wetterberg L. Dopamine metabolism in red blood cells in schizophrenia. Clin Genet. 1981 May;19(5):410–413. [PubMed] [Google Scholar]
  22. Malhotra A. K., Goldman D., Buchanan R., Breier A., Pickar D. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 1996 Jun 29;347(9018):1830–1831. [PubMed] [Google Scholar]
  23. Mant R., Williams J., Asherson P., Parfitt E., McGuffin P., Owen M. J. Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. Am J Med Genet. 1994 Mar 15;54(1):21–26. doi: 10.1002/ajmg.1320540106. [DOI] [PubMed] [Google Scholar]
  24. Matthysse S., Baldessarini R. J. S-adenosylmethionine and catechol-O-methyl-transferase in schizophrenia. Am J Psychiatry. 1972 Apr;128(10):1310–1312. doi: 10.1176/ajp.128.10.1310. [DOI] [PubMed] [Google Scholar]
  25. Moises H. W., Gelernter J., Giuffra L. A., Zarcone V., Wetterberg L., Civelli O., Kidd K. K., Cavalli-Sforza L. L., Grandy D. K., Kennedy J. L. No linkage between D2 dopamine receptor gene region and schizophrenia. Arch Gen Psychiatry. 1991 Jul;48(7):643–647. doi: 10.1001/archpsyc.1991.01810310061011. [DOI] [PubMed] [Google Scholar]
  26. Morris A. G., Gaitonde E., McKenna P. J., Mollon J. D., Hunt D. M. CAG repeat expansions and schizophrenia: association with disease in females and with early age-at-onset. Hum Mol Genet. 1995 Oct;4(10):1957–1961. doi: 10.1093/hmg/4.10.1957. [DOI] [PubMed] [Google Scholar]
  27. Nöthen M. M., Rietschel M., Erdmann J., Oberländer H., Möller H. J., Nober D., Propping P. Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet. 1995 Sep 30;346(8979):908–909. doi: 10.1016/s0140-6736(95)92756-5. [DOI] [PubMed] [Google Scholar]
  28. O'Donovan M. C., Guy C., Craddock N., Murphy K. C., Cardno A. G., Jones L. A., Owen M. J., McGuffin P. Expanded CAG repeats in schizophrenia and bipolar disorder. Nat Genet. 1995 Aug;10(4):380–381. doi: 10.1038/ng0895-380. [DOI] [PubMed] [Google Scholar]
  29. Poitou P., Assicot M., Bohuon C. Soluble and membrane catechol-o-methyl transferases in red blood cells of schizophrenic patients. Biomedicine. 1974 Feb;21(2):91–93. [PubMed] [Google Scholar]
  30. Pulver A. E., Nestadt G., Goldberg R., Shprintzen R. J., Lamacz M., Wolyniec P. S., Morrow B., Karayiorgou M., Antonarakis S. E., Housman D. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis. 1994 Aug;182(8):476–478. doi: 10.1097/00005053-199408000-00010. [DOI] [PubMed] [Google Scholar]
  31. Ravindranathan A., Coon H., DeLisi L., Holik J., Hoff M., Brown A., Shields G., Crow T., Byerley W. Linkage analysis between schizophrenia and a microsatellite polymorphism for the D5 dopamine receptor gene. Psychiatr Genet. 1994 Summer;4(2):77–80. doi: 10.1097/00041444-199422000-00002. [DOI] [PubMed] [Google Scholar]
  32. Sasaki T., Hattori M., Fukuda R., Kunugi H., Nanko S. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 1996 Jun 29;347(9018):1832–1832. [PubMed] [Google Scholar]
  33. Scambler P. J., Kelly D., Lindsay E., Williamson R., Goldberg R., Shprintzen R., Wilson D. I., Goodship J. A., Cross I. E., Burn J. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet. 1992 May 9;339(8802):1138–1139. doi: 10.1016/0140-6736(92)90734-k. [DOI] [PubMed] [Google Scholar]
  34. Schaid D. J., Sommer S. S. Comparison of statistics for candidate-gene association studies using cases and parents. Am J Hum Genet. 1994 Aug;55(2):402–409. [PMC free article] [PubMed] [Google Scholar]
  35. Shaikh S., Gill M., Owen M., Asherson P., McGuffin P., Nanko S., Murray R. M., Collier D. A. Failure to find linkage between a functional polymorphism in the dopamine D4 receptor gene and schizophrenia. Am J Med Genet. 1994 Mar 15;54(1):8–11. doi: 10.1002/ajmg.1320540104. [DOI] [PubMed] [Google Scholar]
  36. Shprintzen R. J., Goldberg R., Golding-Kushner K. J., Marion R. W. Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet. 1992 Jan 1;42(1):141–142. doi: 10.1002/ajmg.1320420131. [DOI] [PubMed] [Google Scholar]
  37. Thibaut F., Martinez M., Petit M., Jay M., Campion D. Further evidence for anticipation in schizophrenia. Psychiatry Res. 1995 Nov 29;59(1-2):25–33. doi: 10.1016/0165-1781(95)02778-5. [DOI] [PubMed] [Google Scholar]
  38. WOOLF B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955 Jun;19(4):251–253. doi: 10.1111/j.1469-1809.1955.tb01348.x. [DOI] [PubMed] [Google Scholar]
  39. White H. L., McLeod M. N., Davidson J. R. Catechol O-methyltransferase in red blood cells of schizophrenic, depressed, and normal human subjects. Br J Psychiatry. 1976 Feb;128:184–187. doi: 10.1192/bjp.128.2.184. [DOI] [PubMed] [Google Scholar]
  40. Williams J., Spurlock G., McGuffin P., Mallet J., Nöthen M. M., Gill M., Aschauer H., Nylander P. O., Macciardi F., Owen M. J. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet. 1996 May 11;347(9011):1294–1296. doi: 10.1016/s0140-6736(96)90939-3. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES